TCL Archive NCAB Considering Concept Review Of Large, Expensive Investigator Initiated Proposals February 16, 1990
TCL Archive Afinitor and Exemestane More Than Doubles PFS, Reduces Progression Risk by 57 Percent September 30, 2011
TCL Archive Commercial Firms Get Foot In The Door With CREG, But Won’t Be Permitted To Make Money On Grants January 10, 1975